SUBSCRIBE
SUBSCRIBE

Phase I

Drug Development
AbbVie’s New Approach To Fighting Cancer At Their Roots
March 29, 2017
 · 
1 min read
How Biogen Makes Most of Its Cash
Drug Development
A Look at Biogen’s Big Bet on the Holy Grail of Science—Alzheimer’s
March 28, 2017
 · 
2 min read
Drug Development
Matinas BioPharma’s Weak Drug Pipeline And Investors With Fraudulent Histories
March 27, 2017
 · 
1 min read
Drug Development
The Science Of Sex’s ‘Afterglow’, Psychological Science, Study Reveals
March 24, 2017
 · 
1 min read
Big-Name Investor Peter Thiel Funds ‘Unethical’ Offshore Herpes Vaccine Trial
Drug Development
Oscar Winner Turned Pharma CEO: We’ll Prevent Genital Herpes
March 8, 2017
 · 
4 min read
Novartis to Hold On to Its 33% Stake in Roche—For Now
Drug Development
Novartis AG Puts Cancer Hopes on 4 Star Scientists Poached From Harvard Last Year
March 1, 2017
 · 
2 min read
Kite Pharma's CAR-T Blood Cancer Candidate Succeeds in Major Study
Drug Development
Kite Pharma’s CAR-T Blood Cancer Candidate Succeeds in Major Study
February 28, 2017
 · 
3 min read
Drug Development
Why 2017 Will be a Data-Rich and Not Revenue-Focused Year for bluebird bio
February 24, 2017
 · 
1 min read
Drug Development
Could Marijuana Be the Next Miracle Drug For Treating Cancer?
February 20, 2017
 · 
1 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Drug Development
3 Biotechs With the Biggest and Most Promising Pipelines
February 16, 2017
 · 
2 min read
Load More
PRESS RELEASES
Drug Development
Pyxis Oncology Advances PYX-106 and PYX-201 Clinical Programs
May 30, 2023
 · 
9 min read
Drug Development
Genprex Receives Safety Review Committee Approval to Advance to Phase 2 Expansion Portion of Acclaim-1 Clinical Trial of REQORSA® in Combination with Tagrisso® in Advanced Non-Small Cell Lung Cancer
May 30, 2023
 · 
9 min read
Drug Development
Immorna Announces First Subject Dosed in a Phase 1 Study of JCXH-105, a Self-Replicating RNA-Based Vaccine Developed for the Prevention of Shingles
May 30, 2023
 · 
3 min read
Drug Development
selectION, Inc., Reports Interim Safety and Tolerability Results of Phase 1b Clinical Trial in Atopic Dermatitis
May 30, 2023
 · 
3 min read
Drug Development
Harbour BioMed Reports Results of Phase Ib Clinical Trial of Porustobart in Combination of Toripalimab in Patients with Hepatocellular Carcinoma at ASCO 2023
May 28, 2023
 · 
4 min read
Drug Development
77.4% ORR! Abbisko to present the updated clinical phase Ib data of Pimicotinib (ABSK021) at the 2023 ASCO Annual Meeting
May 28, 2023
 · 
4 min read
Drug Development
Molecular Templates to Present on Phase I Dose Escalation Study of MT-6402 at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
May 26, 2023
 · 
4 min read
Drug Development
FORE Biotherapeutics to Present Promising New Data from Phase 1/2a Trial Evaluating Plixorafenib (FORE8394) in Patients With BRAF-Altered Advanced Solid and Central Nervous System Tumors at ASCO 2023
May 26, 2023
 · 
9 min read
Drug Development
Innate Pharma Highlights Phase 1/2 Dose Escalation Safety and Preliminary Efficacy of Sanofi Developed First NK Cell Engager SAR’579 / IPH6101 in R/R AML
May 26, 2023
 · 
6 min read
Drug Development
Zentalis Announces Presentation of Positive Phase 1b Data Demonstrating Durable Responses and Favorable Safety Profile of Azenosertib in Combination with Chemotherapy at the 2023 ASCO Annual Meeting
May 25, 2023
 · 
10 min read
Drug Development
Theratechnologies to Present Preliminary Safety and Efficacy Data from Phase 1 Trial of Sudocetaxel Zendusortide in Heavily Pretreated Cancer Patients at ASCO 2023
May 25, 2023
 · 
8 min read
Drug Development
Interim Results From Phase 1/2 Clinical Trial in Solid Tumor Cancers Demonstrate Aulos Bioscience’s AU-007 is Well Tolerated and Uniquely Reduces Regulatory T Cells
May 25, 2023
 · 
6 min read
Drug Development
Shattuck Labs to Present Complete Dose-Escalation Data from Phase 1A Monotherapy Clinical Trial of SL-172154 in Platinum-Resistant Ovarian Cancer (PROC) at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
May 25, 2023
 · 
7 min read
Drug Development
Syros Presents Data from Phase 1/1b Clinical Trial of SY-5609 in Advanced Solid Tumors at ASCO Annual Meeting
May 25, 2023
 · 
7 min read
Drug Development
Pionyr Immunotherapeutics’ Phase 1a Study of TREM1-targeting Antibody PY159 for the Treatment of Solid Tumors Featured at ASCO 2023
May 25, 2023
 · 
6 min read
Drug Development
Artiva Biotherapeutics Presents Initial Data from First-in-Human Phase 1/2 Clinical Trial of AB-101 at the 2023 ASCO Annual Meeting
May 25, 2023
 · 
7 min read
Drug Development
Theseus Pharmaceuticals Reports Initial Dose Escalation Data from Ongoing Phase 1/2 Trial of THE-630 in Patients with Advanced GIST
May 25, 2023
 · 
12 min read
Drug Development
I-Mab Announces Encouraging Phase 1b/2 Study Results of Patients with Advanced NSCLC Receiving Uliledlimab and Toripalimab Combination Therapy at ASCO 2023
May 25, 2023
 · 
7 min read
Drug Development
AffyImmune Therapeutics Announces Positive Safety and Early Efficacy Results from Phase 1 Study of AIC100 CAR T Cells in Anaplastic and Advanced Thyroid Cancers at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
May 25, 2023
 · 
3 min read
Drug Development
Genprex Publishes Positive Clinical Data from Phase 1 Portion of Acclaim-1 Clinical Trial Evaluating REQORSA® Immunogene Therapy in Non-Small Cell Lung Cancer at the 2023 ASCO Annual Meeting
May 25, 2023
 · 
9 min read
Load More